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Abstract
Background: The use of goal directed fluid protocols in intermediate risk patients undergoing hip or knee replacement
was studied in few trials using invasive monitoring. For this reason we have implemented two different fluid
management protocols, both based on a novel totally non-invasive arterial pressure monitoring device and
compared them to the standard (no-protocol) treatment applied before the transition in our academic institution.
Methods: Three treatment groups were compared in this prospective study: the observational (CONTROL, N = 40)
group before adoption of fluid protocols and two randomized groups after the transition to protocol fluid management
with the use of the continuous non-invasive blood pressure monitoring (CNAP®) device. In the PRESSURE group (N = 40)
standard variables were used for restrictive fluid therapy. Goal directed fluid therapy using pulse pressure variation was
used in the GDFT arm (N = 40). The influence on the rate of postoperative complications, on the hospital length of stay
and other parameters was assessed.
Results: Both protocols were associated with decreased fluid administration and maintained hemodynamic
stability. Reduced rate of postoperative infection and organ complications (22 (55 %) vs. 33 (83 %) patients;
p = 0.016; relative risk 0.67 (0.49–0.91)) was observed in the GDFT group compared to CONTROL. Lower number
of patients receiving transfusion (4 (10 %) in GDFT vs. 17 (43 %) in CONTROL; p = 0.005) might contribute to this
observation. No significant differences were observed in other end-points.
Conclusion: In our study, the use of the fluid protocol based on pulse pressure variation assessed using
continuous non-invasive arterial pressure measurement seems to be associated with a reduction in postoperative
complications and transfusion needs as compared to standard no-protocol treatment.
Trial registration: ACTRN12612001014842
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Background
In recent years fluid management protocols and goal-
directed therapy (GDT) have gained popularity among
anesthesiologists [1]. According to recent meta-analyses
GDT is associated with a decreased rate of postopera-
tive complications [2–4] and fluid optimization proto-
cols seem to be the necessary step [5]. A rational fluid
optimization protocol consisting of maintenance infu-
sion covering basal loss and goal-directed top-ups has
been proposed by other authors [6, 7]. However, ac-
cording to a recently published survey among European
and American anesthesiologists [8], protocols for peri-
operative hemodynamic care are lacking in many insti-
tutions. Another important factor stressed by this
survey was the use of dynamic variations of stroke vol-
ume or its surrogates as substitutes of cardiac output
monitoring. In high-risk surgical populations, the stud-
ies by Forget [9] and Lopes [10] as well as one large
meta-analysis of other published trials [11] showed a
positive influence of the dynamic variations-led GDT
even without monitoring of cardiac output. The adop-
tion of dynamic variations is limited in some situations
[12], but can significantly simplify the delivery of fluid
optimization protocols.
Total hip or knee replacements are usually performed
among elderly patients, but neither the chronic health
state nor the procedure-associated risk usually exceed
moderate risk. In one study, hemodynamic optimization
using oxygen delivery targets was associated with favor-
able postoperative outcome [13]. However, such invasive
monitoring might lead to some minor complications
[14], increases the economic burden and is often deemed
unnecessary. The volume clamp method for continuous
non-invasive arterial pressure monitoring or similar
techniques enables the delivery of a fluid therapy proto-
col without these disadvantages.
In this trial we studied the effect of a controlled transi-
tion from non-protocolled to protocolled fluid manage-
ment on the rate of postoperative complications and
other relevant perioperative outcomes in patients under-
going elective total hip and knee replacement. Our hy-
pothesis was that the fluid management protocol guided
by non-invasive continuous arterial pressure and the
easily obtained dynamic predictor of fluid responsiveness
(respiratory variation of the pulse pressure - PPV) would
help to decrease postoperative morbidity.
Methods
The study was performed at the Department of Anesthesia
and Intensive Care Medicine of the Faculty of Medicine
and Charles University Hospital in Plzen. The Institu-
tional review board approved the study which was con-
sequently registered in the primary WHO register
(ACTRN12612001014842), and all patients gave and
signed the informed consent. The study was performed
and reported in accordance with the CONSORT state-
ment [15] (see Additional file 1). The trial followed a
two-stage “before and after” design with one control
observational group and two randomized-protocol
based study groups. All groups consisted of two strata
(total hip replacement - 20 patients and total knee re-
placement – 20 patients). Basic inclusion for all study
participants were: age above 18, general anesthesia,
regular heart rhythm, informed consent and no need
for direct and continuous blood pressure monitoring or
advanced hemodynamic monitoring.
First stage – observational and wash-out period
The CONTROL group was treated according to the
usual care without any fluid protocol. On the day of sur-
gery patients were fasted and received 2 ml/kg/h of crys-
talloid infusion from the morning until transport to the
operation room. Throughout the surgery monitoring of
blood pressure was performed using an automatic oscillo-
metric non-invasive arm cuff (rate of measurement once
every 5 min but there were no restrictions in increasing the
rate). Blood pressure fluctuations within 20 % of the base-
line values were tolerated. The amounts of fluids infused
were at the discretion of the treating anesthesiologist.
Transfusion of red blood cells was indicated when the
hemoglobin fell below 90 g/l; in overall healthy patients
lower thresholds (up to 70 g/l) were tolerated. The blood
loss was assessed by measuring the balance of closed sys-
tem suction. Two independent investigators (JZ and RP)
were responsible for the assessment of the CONTROL
group patients. These two investigators did not participate
in the following course of the study so the outcome data
was concealed.
After completion of the first phase a wash-out period
was interposed. Within this time all study members re-
sponsible for in-study anesthesia delivery (LH, JP and JS)
were trained in the use of the CNAP® monitor and the
protocol (each of them had to perform at least 10 cases
per protocol group).
Second stage – randomized, protocol based
During the second stage all patients undergoing sched-
uled total knee or hip replacement fulfilling mentioned
inclusion criteria were found eligible. Patients were
equally randomized into two groups (GDFT and PRES-
SURE) each with 40 patients, stratified to knee and hip
replacement (20 patients each). Randomization was per-
formed by the study member responsible for the
anesthesia delivery before the induction using sealed
opaque envelope technique stored in non-transparent
containers (one per stratum) with group allocation in a
1:1 ratio. Each envelope, holding one patient’s identifica-
tion, was then returned into another non-transparent
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container which remained sealed till the end of the study
when the concealment was broken for statistical analysis.
This made all other study members as well as the sur-
geon and other health care staff blinded to individual pa-
tient’s allocation.
Anesthesia, monitoring and protocol delivery
All patients were fasted before the procedure, small
amounts of liquids were allowed for those later on the
operating schedule and for chronic medication inges-
tion. During fasting all patients received an infusion of
Hartmann solution (2 ml/kg/h) from the morning of
the operative day. General anesthesia was induced using
propofol (2 mg/kg) and sufentanil (0.2 μg/kg) and tracheal
intubation was facilitated by atracurium or rocuronium
(0.5 mg/kg). Volatile anesthetic (sevoflurane – MAC 0.8–
1.2 accounted for age) in oxygen-N2O mixture was used
for anesthesia maintenance. Opioid or muscle relaxant
increments were used to secure adequate analgesia and
operating conditions. Under relevant circumstances a de-
viation in the usual induction or maintenance was toler-
ated at the discretion of the treating anesthesiologist or
anesthesia consultant.
The CNAP® device (CNSystems, Graz, Austria) was
used for blood pressure monitoring in both protocol
groups (GDFT and PRESSURE). The device works uti-
lizes the principle of volume clamping described by the
Czech physiologist Peňáz in 1963 and adapted later by
Fortin [16]. First, a state of vascular unloading is set by
inflating the cuff around the finger to reach maximal
pulse oscillations (the pressure inside and outside the
arterial wall is then equivalent). Next, the volume of
blood compartment of the finger is measured by plethys-
mography and held constant with the use of fast reacting
inflations/deflations of the cuff. This enables a recon-
struction of the arterial pressure curve at the level of the
fingers. To obtain brachial pressure, the values are cali-
brated at the beginning and every 15 min thereafter
using a standard non-invasive oscillometric measure-
ment in the arm. The device displays blood pressure
continuously, enabling the automatic calculation of the
PPV (pulse pressure variation) and exports the pressure
curve and values to standard monitor (Ultraview
SL2700, Spacelabs Healthcare, Washington, USA). In the
GDFT group all relevant data was shown to the
anesthesiologist. In the PRESSURE group the screen of
the CNAP® device was covered and the continuous arter-
ial pressure curve and values (without PPV) were trans-
ferred to the bedside anesthesia monitor. The values of
the PPV for the analysis were obtained off-line from
stored data after the procedure by a study member (JB)
blinded to patient allocation.
Throughout the procedure fluid therapy was delivered
according to the protocols displayed in Fig. 1a and b
with maintenance infusion of 5 ml/kg/h of crystalloids
(Plasmalyte, Baxter Czech s.r.o., Praha, Czech Republic).
Fig. 1 The protocols of fluid management in the second-stage groups (PRESSURE – panel a; GDFT – panel b). Legend: HR – hear rate; MAP – mean
arterial pressure; PPV – pulse pressure variation; IPPV – Volume controlled ventilation; Vt – Tidal volume; PEEP – Positive End-Expiratory Pressure;
RR – respiratory rate
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Repeated boluses of 3 ml/kg of colloids (preferentially
Gelofusine 4 % or 130/0.4 HES 6 %, Volulyte; both B-
Braun Melsungen, Germany) were used if indicated by
usual pressure targets (PRESSURE group) or by pulse
pressure variation above 13 % (GDFT group). In case of
reaching the maximal dose of colloids (25 ml/kg) crystal-
loid boluses of 3 ml/kg would be used for further care.
When the patient was hypotensive though reaching a
“volume loaded state” (defined as PPV < 13 % or based
on clinical assessment in the GDFT or PRESSURE
groups respectively) a vasoactive rescue medication
(Ephedrine 5–10 mg i.v. bolus or continuous Norepin-
ephrine) was indicated. The decision which drug to
choose was on the discretion of treating anesthesiologist
based on presumed duration of hypotensive period and/
or underlying cause. The number of hypotensive periods
requiring volume loading and/or vasoactive treatment
was collected as well as total dose of vasoactive medica-
tion. The same transfusion threshold (as the CONTROL
group) was used if not required otherwise due to chronic
conditions of the patient.
Study outcomes
The number of patients with any postoperative organ or
infectious complication was the primary outcome meas-
ure of the study. The list of relevant complications was
based on previous GDT trials [13, 17] (Additional file 2).
The treating physician was responsible for the diagnosis
and treatment of all complications. Hospital length of
stay and all-cause mortality were assessed as secondary
outcomes. Fluid balance and lactate levels in the early
(24 h) postoperative period were regarded as safety mea-
sures. Besides the mentioned conditions, other poten-
tially relevant outcomes (i.e. ICU length of stay, duration
of ventilator support, number of blood products used,
hemoglobin level and hemodynamic profile in the intra-
operative and early postoperative period as well as vaso-
active medication used) were assessed. As both the ICU
and hospital lengths of stay might be influenced by many
other factors not relevant to the health care conditions
of the patient, a readiness for standard ward transfer and
for hospital discharge were also evaluated (screening cri-
teria are listed in the Additional file 2). Two investiga-
tors (JB, AS), blinded to study group allocation and not
participating in the anesthesia care and randomization,
evaluated the state of the patients during regular visits.
Statistical analysis
The number of CONTROL group patients was based on
previous observations in similar patient population [13].
A significant reduction of postoperative complication
(odds ratio 0.38) was reported in recent meta-analysis
concerning hemodynamic optimization [2]. Due to in-
clusion of intermediate risk patients we had expected to
observe lower treatment effect. According to the rate of
complications observed in the CONTROL group (33 pa-
tients (83 %)) and to treatment effect expected (conser-
vative reduction from 83 to 50 %) a sample of 36
patients would be necessary (alpha and beta error of
0.05 and 0.2). We have decided to include 40 patients
into each group in order to cover possible “drop outs”
and also to facilitate the division into two strata (total
hip vs. knee replacement).
The analysis was performed using the SigmaStat for
Windows v.3.5 (Systat Software Inc., San Jose, USA).
The Kolmogorov-Smirnoff test was used for normality
assessment. For inter-group comparison one-way
ANOVA or Kruskall-Wallis tests were used respect-
ively. For time-dependent variables, repeated measures
ANOVA or Friedman tests were performed. Post-hoc
analysis was performed with the Student-Newman-
Keul’s or Dunn’s test. Categorical variables were tested
using the Chi-square test. The p < 0.05 was taken as
statistically significant.
Results
During the first stage (August and September 2012), 40
consecutive patients undergoing hip (20 patients) and
knee (20 patients) replacements under general anesthesia
were observed for peri- and postoperative outcomes
(CONTROL group). All patients operated during this
period were included and there were none lost to follow
up. In the second stage (late November 2012 to early
March 2013), a total of 97 hip or knee replacements
were performed under general anesthesia and found eli-
gible for study inclusion. Seventeen patients were ex-
cluded before randomization for various reasons (listed
in Fig. 2), 80 patients were included and equally ran-
domized into two groups each with two strata contain-
ing 20 patients. All patients in both stages gave informed
consent and were included in the final analysis, one of
them died within 30 postoperative days because of pul-
monary embolization. The entire flow chart according to
CONSORT statement is displayed in Fig. 2. No signifi-
cant differences were observed between the three groups
in regard to demographic parameters or chronic comor-
bidities (Table 1).
The results of primary and secondary outcome data are
summarized in Tables 2 and 3. The rate of complications
among patients of the CONTROL group was higher as
compared to both protocol groups. In pair-wise compari-
sons, only the difference between CONTROL and GDFT
reached statistical significance (33 patients (83 %) vs. 22
(55 %); p = 0.02; relative risk 0.67 (95 % confidence interval
0.49–0.91)). The higher number of complications resulted
in a trend towards the prolongation of hospital length of
stay as assessed by readiness for discharge criterion.
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In both protocol groups a trend for lower number of
hypotensive periods was observed intraoperatively with
lower dose of rescue vasoactive therapy. No significant
differences were found between PPV values of both
protocol groups (PRESSURE and GDFT). Pulse pressure
variation was low in both groups in the beginning as
well as at the end of the procedure. The overall fluid
status (amount of fluids administered, blood loss etc.)
was comparable in both protocol groups. Contrarily, the
CONTROL patients received significantly higher
amounts of fluid compared to both groups managed
with protocol. A drop in hemoglobin level was observed
among all patients, but was more pronounced in the
CONTROL group patients (Fig. 3). A higher proportion
of CONTROL patients needed transfusion during early
as well as late postoperative periods. Serum lactate levels
were assessed only in the prospective groups’ patients
and showed no significant differences between PRES-
SURE and GDFT.
Discussion
In our study, the adoption of a fluid administration
protocol guided by pulse pressure variation assessed by
continuous non-invasive arterial pressure monitoring
seems to be associated with lower rate of postoperative
complications compared to standard no-protocol care.
Reduced amounts of infused fluids with maintained
hemodynamic stability, lower dose of rescue vasoactive
medication and lower rate of transfusion requirements
were observed among patients of the GDFT group com-
pared to CONTROL patients.
Fluid administration based on protocols with use of
goal-directed hemodynamic optimization seems to be
Table 1 Baseline and demographic characteristics
CONTROL PRESSURE GDFT P
value(N = 40) (N = 40) (N = 40)
Age (years) 70 (54–84) 66 (44–80) 68 (33–84) 0.145
Sex (F/M) 25/15 26 / 14 23/17 0.789
Height (cm) 167 (8) 166 (9) 169 (11) 0.385
Weight (kg) 82 (15) 82 (15) 90 (16) ab 0.025
ASA (1/2/3) 2/23/15 7/24/9 6/27/7 0.164
Arterial hypertension 30 (75 %) 28 (70 %) 27 (68 %) 0.754
Ischemic heart disease 9 (23 %) 7 (18 %) 4 (10 %) 0.320
Chronic pulmonary disease 6 (15 %) 4 (10 %) 4 (10 %) 0.724
Diabetes mellitus 9 (23 %) 6 (15 %) 10 (25 %) 0.519
Data are presented as mean and range for age, mean (standard deviation) or
number (proportion) for other parameters
a - significant difference between PRESSURE vs. GDFT groups
b - significant difference between protocolled group (GDFT or PRESSURE)
vs. CONTROL
Fig. 2 The flow chart of patients through the trial. Legend: ITT – intention-to-treat analysis
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associated with improved postoperative outcomes in
high risk surgical patients [3]. However, among inter-
mediate risk patients, (for instance total hip or knee re-
placement) the evidence has been scarce and liberal
strategies without proper monitoring are often accepted.
Holte et al. [18] observed lower incidence in postopera-
tive vomiting among patients managed with the liberal
as opposed to the restrictive approach. The authors of
this study hypothesized that preoperative fasting might
influence this outcome and that a liberal regimen helps
to cover the preoperative hypovolemia. According to
values of PPV observed after induction, our patients
were not hypovolemic before the procedure. In such
cases a liberal approach might drive them into hypervo-
lemia and resulting hemodilution. Red blood cell trans-
fusions can exhibit immunosuppressive effect [19] and
lead to increased incidence of infectious complications.
In our study the protocol approach to fluid administra-
tion itself (PRESSURE group) was associated with a
trend towards better clinical outcomes and lower trans-
fusion needs. But it seems that only a complex protocol
(restrictive maintenance with fluid responsiveness as-
sessment- GDFT group) can adapt for the variable blood
loss and individual needs. This is supported by our re-
sults or by the study by Cecconi [13]. In that trial, goal-
directed fluid management was further combined with
Table 2 Intervention data, fluid balance and laboratory outcome
CONTROL PRESSURE GDFT P-value
(N = 40) (N = 40) (N = 40)
Length of the procedure (min) 110 (100–120) 105 (90–118) 100 (85–113) 0.06
MAP before anesthesia (mmHg) 119 (15) 113 (17) 114 (19) 0.31
MAP end of procedure (mmHg) 118 (14) 105 (12)bc 103 (18)bc <0.001
HR before anesthesia (beats per minute) 73 (10) 72 (11) 68 (13) 0.20
HR end of procedure (beats per minute) 74 (14) 78 (16)c 77 (14)c 0.34
PPV after induction N/A 7.9 (4.2) % 8.9 (4.5) % 0.36
PPV end of procedure N/A 7.2 (2.4) % 8.2 (3.8) % 0.15
Hypotensive periods intraoperatively 3 (1–5) 2 (1–4) 2 (0–4) 0.09
Ephedrin (number of interventions) 2 (0–3) 0 (0–1)b 0 (0–1)b <0.001
Ephedrin (dose - mg) 10 (0–15) 0 (0–10) 0 (0–10) 0.11
Hemoglobin before anesthesia (g/l) 136 (11) 121 (12) ab 131 (14) <0.001
Hemoglobin end of procedure (g/l) 117 (15) 110 (13) ab 118 (16) 0.03
Lactate end of procedure (mmol/l) N/A 1.2 (0.4) 1.2 (0.6) 0.99
Intraoperative fluid balance
Blood loss (ml) 500 (300–575) 500 (300–600) 400 (300–600) 0.77
Maintenance fluids (crystalloid) (ml) 1500 (1200–1500) 700 (600–750)b 750 (600–900)b <0.001
Bolus fluids (colloid) (ml) 0 (0–500) 440 (100–500)b 400 (0–500)b 0.01
Patients receiving transfusion 5 (13 %) 3 (8 %) 1 (3 %) 0.24
Number of packed blood cells transfused 0 (0–0) 0 (0–0) 0 (0–0) 0.26
Early postoperative fluid balance (24 h)
Blood loss (ml) 735 (400–805) 470 (390–840) 500 (380–678) 0.42
Diuresis (ml) 1300 (1025–1625) 1000 (785–1378)b 1075 (900–1300)b 0.01
Crystalloids (ml) 2525 (2300–2800) 2800 (2300–3150) 2700 (2350–3125) 0.27
Colloids (ml) 0 (0–0) 0 (0–0) 0 (0–0) 0.70
Patients receiving transfusion 17 (43 %) 11 (28 %) 4 (10 %)b 0.01
Number of packed blood cells transfused 0 (0–2) 0 (0–2) 0 (0–0)b 0.01
Hemoglobin (24 h) (g/l) 105 (10) 102 (12) a 110 (14) a 0.01
Lactate (24 h) (mmol/l) N/A 1.6 (0.8) 1.7 (0.8) 0.67
Data are presented as mean (standard deviation), median (interquartil range) or number (proportion)
PPV pulse pressure variation, HR heart rate, MAP mean arterial pressure
a - significant difference between PRESSURE vs. GDFT groups
b - significant difference between protocolled group (GDFT or PRESSURE) vs. CONTROL
c - significant difference against baseline
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dopexamine infusion in order to reach a predefined goal
of oxygen delivery. Lower incidence of cardiac and minor
organ complications was observed, resembling our data.
However, the use of inotropic support might be ques-
tioned in patients without significant cardiac morbidity
and the use of arterial catheters is also not standard for
these procedures.
The outcomes of the GDFT group patients show that
fluid optimization itself might be sufficient in this
intermediate risk population. Recent meta-analysis demon-
strated that dynamic predictors of fluid responsiveness are
useful as goals of perioperative GDT [11]. Using them is
much easier than complex cardiac output monitoring and
oxygen delivery calculation. In addition, the number of lim-
itations in intermediate risk groups seems to be much
lower than reported by Maguire [12]: atrial fibrillation was
present only in 3 (3 %) out of 97 eligible patients and no
other limitations for the use of PPV were observed among
Table 3 Clinical outcome
CONTROL PRESSURE GDFT P-value
(N = 40) (N = 40) (N = 40)
Rate of complications (all) 33 (83 %) 26 (65 %) 22 (55 %)a 0.03
Rate of complications (major) 3 (8 %) 6 (15 %) 2 (5 %) 0.27
Mortality 0 (0 %) 1 (2.5 %) 0 (0 %) 0.37
Hospital length of stay (days) 10.5 (8–12) 10 (9–12.5) 10 (8.5–13.5) 0.99
Discharge readiness (days) 9 (8–12) 9 (7–12) 8 (7–10) 0.06
ICU length of stay (days) 2 (2–2) 2 (2–3) 2 (2–3) 0.3
ICU readiness (days) 2 (2–2) 2 (2–2) 2 (2–2) 0.38
Number of complications (all) 66 61 35 N/A
Number of complications (major) 3 8 3 N/A
Blood transfusion (patients) 30 (75 %) 25 (63 %) 15 (38 %)a 0.001
Blood transfusion (units) 2 (1–4) 2 (0–4) 0 (0–2) N/A
Complications per group (Number of patients)
Cardiovascular
Minor 2 (5 %) 4 (10 %) 0 (0 %) 0.12
Major 0 (0 %) 1 (2.5 %) 1 (2.5 %) 0.6
Respiratory
Minor 1 (2.5 %) 1 (2.5 %) 0 (0 %) 0.6
Major 0 (0 %) 1 (2.5 %) 0 (0 %) 0.37
Infectious
Minor 23 (57.5 %) 9 (22.5 %)a 9 (22.5 %)a 0.001
Major 2 (5 %) 3 (7.5 %) 2 (5 %) 0.86
Renal
Minor 5 (12.5 %) 7 (17.5 %) 5 (12.5 %) 0.76
Major 0 (0 %) 0 (0 %) 0 (0 %) 1
GIT
Minor 20 (50 %) 17 (42.5 %) 11 (27.5 %) 0.12
Major 0 (0 %) 0 (0 %) 0 (0 %) 1
Nervous
Minor 1 (2.5 %) 3 (7.5 %) 3 (7.5 %) 0.55
Major 0 (0 %) 0 (0 %) 0 (0 %) 1
Coagulation
Minor 6 (15 %) 7 (17.5 %) 3 (7.5 %) 0.39
Major 1 (2.5 %) 2 (5 %) 0 (0 %) 0.36
Data are presented as median (interquartil range) or number (proportion)
ICU intensive care unit, GIT gastro-intestinal tract
a - significant difference between protocolled group (GDFT or PRESSURE) vs. CONTROL
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our patients. The ventilation strategy (tidal volume of
8 ml/kg and positive end expiratory pressure of 0.6 kPa) is
in line with recent recommendations for intraoperative
protective ventilation [20], but still enabling the use of dy-
namic variations. An important aspect of our trial is that
the protocol was based on measurements obtained totally
non-invasively.
Our study is the first one using the novel non-invasive
continuous pressure device based on volume-clamped
method for goal-directed treatment. Both the reliability
and limits of the measurement should be recognized,
even though the device is marketed worldwide and ap-
proved by most certification authorities. As for now
three large scale [21–23] and multiple smaller studies
demonstrated the validity of the pressure values ob-
tained by the CNAP® monitor, showing acceptable agree-
ment with direct arterial pressure monitoring. Some
inaccuracies seem to exist in cases of profound pressure
fluctuations (i.e. deep hypotension following anesthesia
induction etc.). The trending ability remained unaffected
by these inaccuracies [24, 25]. In addition, as pointed
out by Hahn [22], the device uses the oscillometric cuff
as a reference, making it equivalent to contemporary
practice in the studied population. It was demonstrated
by our group [26] as well as by others [27, 28] that the
use of continuous non-invasive pressure monitoring de-
vices enables faster recognition of blood pressure drops
and helps to maintain the hemodynamic stability during
surgery. The reliability of the PPV values obtained by the
CNAP® monitor was tested recently by two studies and
was found to be comparable to its invasively assessing
counterparts [29, 30]. Given these positive factors, the
CNAP® device is already widely and routinely used in
many clinical institutions; therefore our study could
serve as a proof of concept for this praxis.
The design of our study poses an important selection
and assessment bias and hence limits the generalizability
of our results. Firstly, the use of a two-stage (“before and
after”) design does not allow us to compare the CON-
TROL group and protocol groups in parallel. However,
our aim was to quantify the effect of change in approach
during the unique moment of transition between no-
protocol and protocol-led care. In order to avoid selec-
tion bias, all patients undergoing the procedure within
the defined stages were found eligible. In the first stage
there were no dropouts and only a limited number of
patients was excluded during the second stage. Sec-
ondly, our study was not set to evaluate between the
groups of phase two so we can derive only indirect
conclusions in regard of superiority of the goal-
directed fluid optimization over the restrictive regimen.
This observed difference resulted mainly from the lower
incidence of minor infectious complications (mostly urin-
ary tract and surgical site infections). Besides blood and
fluids management this might also be confounded by a
slightly uneven distribution of comorbidities. Even though
not statistically significant, patients in the GDFT group
tended to be healthier. This could influence both the
Fig. 3 Haemoglobin levels in perioperative period. Legend: # - significant difference PRESSURE vs. GDFT groups; $ - significant difference PRESSURE vs.
CONTROL groups; * - significant difference GDFT vs. CONTROL groups (all ANOVA with Student-Neuman-Keul’s post hoc analysis); the drop against
baseline measurement was significant in all groups and time-points
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transfusion trigger and also the risk for complications as
well as help reach the predefined readiness for discharge
criteria earlier.
Beside these specific limitations, our trial suffers from
flaws inherent to single centre studies with “keen investi-
gators” and a low number of patients. This might be es-
pecially true for intermediate risk patients with a low
number of complications. For this reason our conclu-
sions should be regarded as a hypothesis generating at
best. A much larger study would be necessary to prove
this concept. However, it seems that the use of the con-
tinuous non-invasive arterial pressure device might offer
a safe alternative for monitoring and enable better adop-
tion of fluid protocols.
Conclusions
In conclusion, in our study the transition from standard
no-protocol treatment to the fluid management protocol
based on pulse pressure variation assessed by continuous
non-invasive arterial pressure measurement seems to be
associated with reduction of postoperative infections, of
organ complications, and of transfusion needs.
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